Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ikena Oncology Inc (NQ: IKNA )

3.450 -0.160 (-4.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40,796
Open 3.600
Bid (Size) 3.380 (2)
Ask (Size) 3.460 (2)
Prev. Close 3.610
Today's Range 3.350 - 3.930
52wk Range 1.940 - 8.305
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Credit Suisse Maintains Outperform Rating for Ikena Oncology: Here's What You Need To Know
 
Via Benzinga
Ikena Oncology Earnings Perspective: Return On Capital Employed
 
Via Benzinga

Performance

YTD
+31.68%
+31.68%
1 Month
-15.02%
-15.02%
3 Month
+31.68%
+31.68%
6 Month
-1.71%
-1.71%
1 Year
-42.98%
-42.98%

More News

Read More
Ikena Oncology Reports Fourth Quarter and Full Year 2022 Financial Results
From Ikena Oncology, Inc.
Via Globe NewsWire
Ikena Oncology Presents Preclinical Data on IK-595, Best-in-Class Next-Generation MEK-RAF Complex Inhibitor, in Plenary Session at AACR Special Conference on RAS Targeting
From Ikena Oncology, Inc.
Via Globe NewsWire
Ikena Oncology Receives FDA Fast Track Designation for Novel AHR Antagonist IK-175 in Combination with Nivolumab to Treat Urothelial Carcinoma
From Ikena Oncology, Inc.
Via Globe NewsWire
Ikena Oncology's Return On Capital Employed Insights
Via Benzinga
Ikena Oncology: Q3 Earnings Insights
Via Benzinga
Ikena Oncology to Participate in Cowen 43rd Annual Health Care Conference
From Ikena Oncology, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Ikena Oncology Appoints Owen Hughes as Board Chair
From Ikena Oncology, Inc.
Via Globe NewsWire
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Ikena Oncology Announces New Cancer Program, Shelves Early Asset For Colorectal Cancer
Via Benzinga
Ikena Oncology Announces New Program in Next-Generation MEK-RAF Inhibition and Provides Corporate Update
From Ikena Oncology, Inc.
Via Globe NewsWire
Ikena Oncology to Participate in the Piper Sandler 34th Annual Healthcare Conference
From Ikena Oncology, Inc.
Via Globe NewsWire
Ikena Oncology Announces Initial Clinical Data from IK-175 Program in Urothelial Carcinoma
From Ikena Oncology, Inc.
Via Globe NewsWire
UPDATE -- Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
From Ikena Oncology, Inc.
Via Globe NewsWire
Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
From Ikena Oncology, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Ikena Oncology Presents Preclinical Data at the 34th EORTC-NCI-AACR Symposium on Novel TEAD Inhibitor, IK-930, Combating Therapeutic Resistance
From Ikena Oncology, Inc.
Via Globe NewsWire
Ikena Oncology Provides Research & Development Update on IK-930 Program Targeting the Hippo Pathway
From Ikena Oncology, Inc.
Via Globe NewsWire
Ikena Oncology to Present Initial Phase 1a/b Results from Novel AHR Inhibition Program at the 2022 Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
From Ikena Oncology, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.